Actively Recruiting
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Led by Istituto Oncologico Veneto IRCCS · Updated on 2026-04-13
24
Participants Needed
1
Research Sites
240 weeks
Total Duration
On this page
Sponsors
I
Istituto Oncologico Veneto IRCCS
Lead Sponsor
I
IGEA
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an monocenter, single arm, clinical investigation that evaluate the impact of the method on the objective response rate (ORR) of visceral lesions undergoing electrochemotherapy. Electrochemotherapy is a well-defined method for the treatment of cutaneous and subcutaneous metastases of different tumor histotypes. Although still limited, the various experiences in the treatment of visceral localizations, particularly in liver metastases from colorectal cancer are promising and show that electrochemotherapy is a safe treatment, even in the case of lesions near large vessels or nerves. The investigators therefore propose a clinical investigation with a Medical Device according to EU Regulation 745/2017, using electrochemotherapy (Cliniporator) with bleomycin for the treatment of visceral, primary or secondary, unresectable localizations, with percutaneous or intraoperative technique (laparoscopic or laparotomy), as needed.
CONDITIONS
Official Title
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 years or older
- Able to understand and agree to the treatment by signing informed consent
- Diagnosed with primary or secondary visceral tumors of any histotype
- Not eligible for standard curative treatments
You will not qualify if you...
- Absolute contraindications to invasive procedures
- Presence of brain, lung, or bone metastases
- Uncorrectable blood clotting problems
- Allergy to bleomycin
- Absolute contraindications to bleomycin
- Poor lung function or pulmonary fibrosis
- Acute lung infections
- Pregnant, breastfeeding, or planning to conceive or father a child during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Oncologico Veneto
Padova, Italy, 35128
Actively Recruiting
Research Team
F
Francesco Russano, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here